Gastroenterology
Volume 120, Issue 4 , Pages 946-954, March 2001

Octreotide for acute esophageal variceal bleeding: A meta-analysis☆☆☆

*Division of Gastroenterology, University of California, San Francisco; *UCSF Gastroenterology Clinical, Outcomes, and Epidemiology Research Group; §Medical Service, San Francisco General Hospital; ‡Department of Epidemiology and Biostatistics, University of California, San Francisco; and ∥General Internal Medicine Section, Department of Veterans Affairs Medical Center, San Francisco, California

Received 2 December 1999; accepted 26 October 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by American Digestive Health Foundation Outcomes Research Training Award, National Institutes of Health Institutional Training Grant, and National Institutes of Health Mentored Clinical Scientist Award. Two of the authors (D.A.C., J.P.C.) have previously received unrestricted grants from Novartis Pharmaceutica (East Hanover, NJ), the manufacturer of octreotide.

☆☆ Address requests for reprints to: Douglas A. Corley, M.D., M.P.H., S-357, UCSF, Box 0538, San Francisco, California 94143-0538. Fax: (415) 476-0659.

PII: S0016-5085(01)49673-9

Gastroenterology
Volume 120, Issue 4 , Pages 946-954, March 2001

Article Tools

* Image Usage & Resolution